经导管超选择性栓塞治疗巨大肝海绵状血管瘤  

Transcatheter superselective embolization in giant hepatic cavernous hemangioma

作　　者：于宝林[1] 段峰[2] 朱承斌[1] 陈庆军[1] 孙志涛[1] 汪树丹[1] 王茂强[2] 

机构地区：[1]鸡西矿业集团总医院介入放射科,黑龙江鸡西158100 [2]中国人民解放军总医院介入放射科,北京100853

出　　处：《生物医学工程与临床》2010年第6期513-516,共4页Biomedical Engineering and Clinical Medicine

摘　　要：目的评价经导管超选择性插管治疗巨大肝海绵状血管瘤(CHL)的安全性及治疗效果。方法 27例直径大于5cm的巨大CHL患者,其中男性8例,女性19例;年龄38～64岁,平均年龄47.3岁。使用同轴微导管行超选择性插管,根据病灶大小采用平阳霉素、超液化碘油、2%利多卡因、庆大霉素制成乳剂12.5～22.5mL进行栓塞治疗,术后随访6～9个月。结果所有病例均治疗成功,术后6个月全部瘤体直径均小于4cm,25例肝血管瘤体积缩小大于50%,所有患者无严重并发症出现。结论经导管超选择性栓塞治疗巨大CHL安全性高,治疗效果好,应作为巨大CHL的首选治疗方法。Objective To evaluate the safety and efficacy of transcatheter superselective embolization for giant cavernous hemangioma of liver（CHL）.Methods A total of 27 patients with giant CHL greater than 5 cm diameter were enrolled,male 8,female 19,aged 38-64 years old,mean age 47.3 years old.Transcatheter superselective embolization was performed by Pingyangmycin,lipiodol,2 % lidocaine and gentamicin emulsion 12.5-22.5 mL for different tumor size,the follow-up duration ranged from 6 to 9 months.Results All procedures were successful without serious complications,all of tumors were remained less than 4 cm in diameter after 6 months,25 cases of hepatic hemangioma volume decreased more than 50 %.Conclusion It is demonstrated that transcatheter superselective embolization is a safe and effective treatment for giant CHL.It should be adopted as the first choice approach for treating giant CHL.

关 键 词：治疗栓塞 肝 海绵状血管瘤 介入放射学 

分 类 号：R735.7[医药卫生—肿瘤]